Skip to content
Open in App
Shandong Boyuan Pharmaceutical

Shandong Boyuan Pharmaceutical

web2

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, pr...

Stage
Undisclosed
Funding
Undisclosed
Team
0
0.0Mission ScoreFixed 0-100 scale

About

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, cesium iodide, potassium iodate, methyl iodide, diiodomethane, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, tris(dioxa-3,6-heptyl)amine, tris(2-(2-methoxyethoxy)ethyl)amine, and tris(3,6-dioxaheptyl)amine. It also provides chemiluminescent products comprising 3,5-dichlorosalicylic acid; 3,5,6-trichlorosalicylic acid; bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate; and bis(2,4,5-trichloro-6-i-pentoxycarbonylphenyl) oxalate. In addition, the company offers precious metal catalysts, such as rhodium(ii) octanoate dimer, rhodium(iii) iodide, wilkinson’s catalyst, palladium acetate, rhodium(iii) chloride hydrate, palladium chloride, chloroplatinic acid hexahydrate, potassium platinochloride, potassium hexachloroplatinate, ruthenium(iii) chloride hydrate, rhodium (triphenylphosphine)carbonylacetylacetonate, tetrakis(triphenylphosphine)palladium, palladium on carbon, and ruthenium on carbon. Further, its products are used in the field of pharmaceuticals, food, feed, chemical industry, new materials, optoelectronic materials, etc. Additionally, the company exports its products. Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. was founded in 2008 and is headquartered in Shouguang, China.

Expert Insight
Shandong Boyuan Pharmaceutical profile.

Expert Coverage

No published expert evaluations are available for this project yet.

PharmaceuticalsHealthcare
0team
0evaluations
0subscribers